Insilico Medicine’s Feng Ren discusses AI drug discovery, clinical development and Asia’s role in turning computational ...

The University of Melbourne, Australia and the Indian Institute of Science Education and Research (IISER) Tirupati have ...

Singapore and global biopharmaceutical company Boehringer Ingelheim will be investigating new approaches to treating obesity, ...

Japan's Ono Pharma inks exclusive license agreement with Biohaven to develop and commercialise IgG degraders in Japan, South ...

In addition to the NMPA's approval of CAMCEVI ® 42 mg for advanced prostate cancer described above, GenSci submitted a ...

Philanthropy Asia Alliance backs the NUS Medicine-based Southeast Asia Heat Health Hub, supporting heat-health action in ...

Australia-based Firebrick Pharma has secured firm commitments from strategic investors for approximately $732k, through the ...

S$25 million Healthy Longevity Institute and global brain health collaboration to advance healthy ageing in Singapore ...

Since acquiring the global rights to edaravone, a treatment for amyotrophic lateral sclerosis (ALS), known as RADICAVA ® in ...

Japan-based Shimadzu Corporation has started the development and validation of a mass spectrometry (MS) solution for core ...

NUS launches S$50M National Centre for Engineering Biology to accelerate AI-guided sustainable biomanufacturing ...

Germfree has launched a configurable Grade A aseptic biopharmaceutical isolator designed to support contamination control and ...